Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 184.09

-0.9%

Dec 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Flagrante Delictu who wrote (18532)	4/3/1998 5:59:00 AM
From: Henry Niman	Read Replies (2) of 32384

Bernie, I had a chance to look at the uploaded table on LGND's pipeline ( home.att.net )and there are a few updates that are of interest. I was a bit surprised to see a Targretin oral Phase II/III Breast Cancer trial listed. As you know, LGND has indicated that they were going to pursue breast cancer very aggressively, but the recent 10-K suggests that such a trial has already begun. Another area of interest is the small molecule program with SBH using STAT technology. The hematopoietic growth factor group (and interferon agonists) is characterized as "lead compound selected" which suggests that they indeed to have compounds that work on humans (the G-CSF compound recently described at Lake Tahoe was mouse specific). Finally, in the area of androgen antagonists, the category is in the "development candidate" category, indicating that the series is ready for IND filing. I wouldn't be surprised to see an NDA for prostate cancer filed by LGND, and a major alliance for cosmeceuticals and BPH.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next